Form 8-K - Current report:
SEC Accession No. 0001013762-25-003342
Filing Date
2025-03-27
Accepted
2025-03-27 16:01:23
Documents
18
Period of Report
2025-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0235810-8k_pmgchold.htm   iXBRL 8-K 54962
2 FORM OF PRE-FUNDED WARRANT ea023581001ex4-1_pmgchold.htm EX-4.1 107419
3 FORM OF SECURITIES PURCHASE AGREEMENT ea023581001ex10-1_pmgchold.htm EX-10.1 221391
4 FORM OF PLACEMENT AGENCY AGREEMENT ea023581001ex10-2_pmgchold.htm EX-10.2 170775
5 FIRST AMENDMENT TO LICENSE AGREEMENT BETWEEN NORTHSTRIVE BIOSCIENCES INC. AND MO ea023581001ex10-3_pmgchold.htm EX-10.3 19520
6 PRESS RELEASE DATED MARCH 21, 2025 ea023581001ex99-1_pmgchold.htm EX-99.1 8151
  Complete submission text file 0001013762-25-003342.txt   903306

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE elab-20250321.xsd EX-101.SCH 3026
8 XBRL LABEL FILE elab-20250321_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE elab-20250321_pre.xml EX-101.PRE 22366
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0235810-8k_pmgchold_htm.xml XML 3797
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25779185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)